SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-19-005319
Filing Date
2019-02-06
Accepted
2019-02-06 16:07:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv512411_sc13ga.htm SC 13G/A 31097
  Complete submission text file 0001144204-19-005319.txt   32793
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Subject) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46247 | Film No.: 19571629
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address NO 16 STREET, XIASHA ECONOMIC TECH DEVELOPMENT HANGZHOU ZHEJIANG F4 31008
Business Address NO 16 STREET, XIASHA ECONOMIC TECH DEVELOPMENT HANGZHOU ZHEJIANG F4 31008 8657186913770
Zhejiang Kanglaite Group Co., LTD (Filed by) CIK: 0001669491 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 1231
Type: SC 13G/A